BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26952094)

  • 1. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
    Gonçalves BP; Tiono AB; Ouédraogo A; Guelbéogo WM; Bradley J; Nebie I; Siaka D; Lanke K; Eziefula AC; Diarra A; Pett H; Bougouma EC; Sirima SB; Drakeley C; Bousema T
    BMC Med; 2016 Mar; 14():40. PubMed ID: 26952094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether-lumefantrine.
    Shekalaghe S; Mosha D; Hamad A; Mbaga TA; Mihayo M; Bousema T; Drakeley C; Abdulla S
    Malar J; 2020 Jan; 19(1):34. PubMed ID: 31964380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
    Eziefula AC; Bousema T; Yeung S; Kamya M; Owaraganise A; Gabagaya G; Bradley J; Grignard L; Lanke KH; Wanzira H; Mpimbaza A; Nsobya S; White NJ; Webb EL; Staedke SG; Drakeley C
    Lancet Infect Dis; 2014 Feb; 14(2):130-9. PubMed ID: 24239324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
    Roth JM; Sawa P; Omweri G; Osoti V; Makio N; Bradley J; Bousema T; Schallig HDFH; Mens PF
    Malar J; 2018 Jun; 17(1):223. PubMed ID: 29866116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mwaiswelo R; Ngasala BE; Jovel I; Gosling R; Premji Z; Poirot E; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2016 Jun; 15():316. PubMed ID: 27287612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
    Wampfler R; Hofmann NE; Karl S; Betuela I; Kinboro B; Lorry L; Silkey M; Robinson LJ; Mueller I; Felger I
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005753. PubMed ID: 28732068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
    Bousema T; Okell L; Shekalaghe S; Griffin JT; Omar S; Sawa P; Sutherland C; Sauerwein R; Ghani AC; Drakeley C
    Malar J; 2010 May; 9():136. PubMed ID: 20497536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.
    Lin JT; Lon C; Spring MD; Sok S; Chann S; Ittiverakul M; Kuntawunginn W; My M; Thay K; Rahman R; Balasubramanian S; Char M; Lanteri CA; Gosi P; Ubalee R; Meshnick SR; Saunders DL
    PLoS One; 2017; 12(6):e0168702. PubMed ID: 28591198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
    Okebe J; Bousema T; Affara M; Di Tanna GL; Dabira E; Gaye A; Sanya-Isijola F; Badji H; Correa S; Nwakanma D; Van Geertruyden JP; Drakeley C; D'Alessandro U
    EBioMedicine; 2016 Nov; 13():348-355. PubMed ID: 27825738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
    Karl S; Laman M; Moore BR; Benjamin J; Koleala T; Ibam C; Kasian B; Siba PM; Waltmann A; Mueller I; Woodward RC; St Pierre TG; Davis TM
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4489-96. PubMed ID: 25987625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
    Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group
    Lancet Infect Dis; 2015 Jun; 15(6):692-702. PubMed ID: 25788162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
    Sawa P; Shekalaghe SA; Drakeley CJ; Sutherland CJ; Mweresa CK; Baidjoe AY; Manjurano A; Kavishe RA; Beshir KB; Yussuf RU; Omar SA; Hermsen CC; Okell L; Schallig HD; Sauerwein RW; Hallett RL; Bousema T
    J Infect Dis; 2013 Jun; 207(11):1637-45. PubMed ID: 23468056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
    Omondi P; Burugu M; Matoke-Muhia D; Too E; Nambati EA; Chege W; Musyoka KB; Thiongo K; Otinga M; Muregi F; Kimani F
    Malar J; 2019 Dec; 18(1):398. PubMed ID: 31801562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.